ARCHIVES

Two Reports Offer Definitions, Plans For Comparative Effectiveness Research

This article is from The Cancer Letter archive.

Vol. 35 No. 26 | July 3, 2009

Download PDF Visit The Full Archive

Related Articles

MEPACT Approved In Europe For Resectable Osteosarcoma

March 27, 2009

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

September 26, 1997

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

Deluge Of SBIR Contract Proposals Changes Picture at NCI, Could Save $5 Million For Cancer

April 12, 1985

In Brief: Kovac, Bunn Lead AACI; Hollings Researcher Wins Immunology Award; Turrisi Moves To SC

September 16, 1994